nevirapine has been researched along with Diathesis in 1 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nevirapine (NVP), is an HIV-1 antiretroviral with treatment-limiting hypersensitivity reactions (HSRs) associated with multiple class I and II HLA alleles." | 1.46 | Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. ( Bracey, A; Buus, S; Carrington, M; Chopra, A; Gaudieri, S; Haas, DW; Hunt, DF; Jing, Y; Kaever, T; Koelle, D; Malaker, SA; Mallal, S; McKinnon, EJ; Myers, P; Ostrov, DA; Pavlos, R; Peters, B; Phillips, EJ; Redwood, A; Restrepo, S; Rive, C; Schutte, R; Shabanowitz, J; Speers, E, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pavlos, R | 1 |
| McKinnon, EJ | 1 |
| Ostrov, DA | 1 |
| Peters, B | 1 |
| Buus, S | 1 |
| Koelle, D | 1 |
| Chopra, A | 1 |
| Schutte, R | 1 |
| Rive, C | 1 |
| Redwood, A | 1 |
| Restrepo, S | 1 |
| Bracey, A | 1 |
| Kaever, T | 1 |
| Myers, P | 1 |
| Speers, E | 1 |
| Malaker, SA | 1 |
| Shabanowitz, J | 1 |
| Jing, Y | 1 |
| Gaudieri, S | 1 |
| Hunt, DF | 1 |
| Carrington, M | 1 |
| Haas, DW | 1 |
| Mallal, S | 1 |
| Phillips, EJ | 1 |
1 other study available for nevirapine and Diathesis
| Article | Year |
|---|---|
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles.
Topics: Alleles; Anti-HIV Agents; Case-Control Studies; Disease Susceptibility; Drug Hypersensitivity; Histo | 2017 |